Cell Freezing Media Market Report 2026

Cell Freezing Media Market Overview

• Cell Freezing Media market size has reached to $1.77 billion in 2025 • Expected to grow to $3 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Rising Demand For Personalized Medicine Fueling The Growth Of The Market Due To Increasing Need For Patient-Specific Cryopreservation Solutions • Market Trend: Advanced Cryopreservation Media Enhances Cell Viability And Functionality • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Freezing Media Market?

Cell freezing media is a specialized solution used to preserve living cells at very low temperatures, typically in liquid nitrogen, to maintain their viability and functionality over extended periods. It usually contains cryoprotective agents that prevent ice crystal formation and maintain cell integrity during the freezing and thawing process. This media is used to enable long-term storage of biological samples for research, therapeutic, or diagnostic applications, ensuring cells remain healthy and recoverable after thawing. The main types of cell freezing media include dimethyl sulfoxide (DMSO), glycerol, sucrose, ficoll, and serum-based media. Dimethyl sulfoxide (DMSO) is an organic solvent widely used as a cryoprotectant in cell freezing media to prevent ice crystal formation and preserve cell viability during cryogenic storage. The different cell culture types involved are suspension cell culture, 2D cell culture, 3D cell culture, and others and are distributed through various channels, including direct sales, distributors, e-commerce platforms, retail outlets, and specialized scientific instrumentation suppliers. It finds applications in stem cell research, embryonic cell preservation, hematopoietic cell preservation, tissue sample storage, and gene therapy applications, and caters to several end-users, such as academic research institutions, biotechnology companies, pharmaceutical companies, clinical laboratories, and contract research organizations (CROs).

What Is The Cell Freezing Media Market Growth Forecast?

The cell freezing media market size is expected to see rapid growth in the next few years. It will grow to $3 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing development of cell and gene therapies, rising demand for large-scale cell banking, expansion of personalized medicine research, growing regulatory requirements for cell storage quality, increasing adoption of automated cryopreservation systems. Major trends in the forecast period include increasing adoption of ready-to-use cryopreservation media, rising demand for serum-free freezing media, growing use of gmp-grade cryoprotectants, expansion of long-term cell banking practices, enhanced focus on post-thaw cell recovery.

Global Cell Freezing Media Market Segmentation

1) By Type: Dimethyl Sulfoxide (DMSO), Glycerol, Sucrose, Ficoll, Serum-Based Media 2) By Cell Culture Type: Suspension Cell Culture, 2D Cell Culture, 3D Cell Culture, Other Cell Culture Types 3) By Distribution Channel: Direct Sales, Distributors, E-Commerce Platforms, Retail Outlets, Specialized Scientific Instrumentation Suppliers 4) By Application: Stem Cell Research, Embryonic Cell Preservation, Hematopoietic Cell Preservation, Tissue Sample Storage, Gene Therapy Applications 5) By End-User: Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Clinical Laboratories, Contract Research Organizations (CROs) Subsegments: 1) By Dimethyl Sulfoxide (DMSO): Pharmaceutical Grade Dimethyl Sulfoxide, Laboratory Grade Dimethyl Sulfoxide, Industrial Grade Dimethyl Sulfoxide, High Purity Dimethyl Sulfoxide 2) By Glycerol: Pharmaceutical Grade Glycerol, Analytical Grade Glycerol, Biological Grade Glycerol, Synthetic Grade Glycerol 3) By Sucrose: Pharmaceutical Grade Sucrose, Analytical Grade Sucrose, Biological Grade Sucrose, Crystalline Sucrose 4) By Ficoll: Ficoll 400, Ficoll 70, Ficoll PM 400 Solution, Low Viscosity Ficoll 5) By Serum-Based Media: Fetal Bovine Serum Based Media, Human Serum Based Media, Horse Serum Based Media, Newborn Calf Serum Based Media

What Is The Driver Of The Cell Freezing Media Market?

The rising demand for personalized medicine is expected to propel the growth of the cell freezing media market going forward. Personalized medicine is a medical approach that involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize outcomes and improve care. The demand for personalized medicine is increasing due to advancements in genomic technologies, which enable the precise identification of genetic variations and tailored treatments for individuals. Cell freezing media enhances personalized medicine by providing reliable cryopreservation solutions that preserve patient-specific cells, tissues, and biologics. It ensures high post-thaw viability and functionality, supporting the development of tailored therapies and improving treatment outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the rising demand for personalized medicine is driving the growth of the cell freezing media industry.

Key Players In The Global Cell Freezing Media Market

Major companies operating in the cell freezing media market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, FUJIFILM Corporation, Lonza Group Ltd., Avantor Inc., Sartorius AG, BioRad Laboratories Inc., BioTechne Corporation, Miltenyi Biotec GmbH, Stemcell Technologies Inc., Vitrolife AB, American Type Culture Collection (ATCC), Bio-Life Solutions Inc., Nacalai Tesque Inc., PromoCell GmbH, Nippon Genetics Co. Ltd., Nippon Zenyaku Kogyo Co. Ltd., Quality Biological Inc., Corning Incorporated

Global Cell Freezing Media Market Trends and Insights

Major companies operating in the cell freezing media market are focusing on developing advanced products, such as specialized cryopreservation media, to boost efficiency, enhance cell viability, and accelerate therapeutic development. Specialized cryopreservation media refer to formulated solutions designed to preserve cells, tissues, or biological materials at very low temperatures while maintaining their viability, functionality, and structural integrity. For instance, in April 2024, Pluristyx Inc., a US-based biotechnology company, launched PluriFreeze. It is a xeno-free and serum-free cGMP-manufactured media designed to improve post-thaw recovery and function of a wide range of cell types, including stem cells and immune cells. It is engineered to provide a robust, ready-to-use formulation that ensures high cell viability and functionality, supporting the transition of therapies from research to clinical application. PluriFreeze improves post-thaw cell viability, manufacturing efficiency, and reproducibility in stem cell and cell therapy development processes.

What Are Latest Mergers And Acquisitions In The Cell Freezing Media Market?

In April 2025, BioLife Solutions Inc., a US-based biotechnology company, acquired PanTHERA CryoSolutions Inc. for an undisclosed amount. With this acquisition, BioLife Solutions gains access to PanTHERA’s proprietary ice recrystallization inhibitor (IRI) technology, thereby enhancing its cryopreservation media portfolio while improving product performance, research reach, and customer value in cell and gene therapy biomanufacturing. PanTHERA CryoSolutions Inc. is a Canada-based biotechnology company specializing in the development and manufacture of cell freezing media and cryopreservation solutions.

Regional Outlook

North America was the largest region in the cell freezing media market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Freezing Media Market?

The cell freezing media market consists of sales of cryovials, freezing containers, cryogenic storage bags, controlled-rate freezers, cryopreservation buffers, and freezing solution kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Freezing Media Market Report 2026?

The cell freezing media market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell freezing media industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.